Understanding the Dynamics of the Structural States of Cannabinoid Receptors and the Role of Different Modulators
Open Access
Abstract
The cannabinoid receptors CB1R and CB2R are members of the G protein-coupled receptor (GPCR) family. These receptors have recently come to light as possible therapeutic targets for conditions affecting the central nervous system. However, because CB1R is known to have psychoactive side effects, its potential as a drug target is constrained. Therefore, targeting CB2R has become the primary focus of recent research. Using various molecular modeling studies, we analyzed the active, inactive, and intermediate states of both CBRs in this study. We conducted in-depth research on the binding properties of various groups of cannabinoid modulators, including agonists, antagonists, and inverse agonists, with all of the different conformational states of the CBRs. The binding effects of these modulators were studied on various CB structural features, including the movement of the transmembrane helices, the volume of the binding cavity, the internal fluids, and the important GPCR properties. Then, using in vitro experiments and computational modeling, we investigated how vitamin E functions as a lipid modulator to influence THC binding. This comparative examination of modulator binding to CBRs provides significant insight into the mechanisms of structural alterations and ligand affinity, which can directly help in the rational design of selective modulators that target either CB1R or CB2R.Keywords
Funding Information
- NSF (CNS-1625061)
- US ARL (W911NF-16-2-0189)
- National Institutes of Health (P30GM122733-01A)
This publication has 79 references indexed in Scilit:
- Cannabinoids, endocannabinoids, and cancerCancer and Metastasis Reviews, 2011
- Activation mechanism of theβ2-adrenergic receptorProceedings of the National Academy of Sciences, 2011
- OPM database and PPM web server: resources for positioning of proteins in membranesNucleic Acids Research, 2011
- Fpocket: An open source platform for ligand pocket detectionBMC Bioinformatics, 2009
- A high cannabinoid CB1 receptor immunoreactivity is associated with disease severity and outcome in prostate cancerEuropean Journal of Cancer, 2009
- Cannabinoid CB2receptors: a therapeutic target for the treatment of inflammatory and neuropathic painBritish Journal of Pharmacology, 2008
- CB2 receptors as new therapeutic targets for liver diseasesBritish Journal of Pharmacology, 2008
- Cannabinoids in pancreatic cancer: Correlation with survival and painInternational Journal of Cancer, 2007
- Ewald summation techniques in perspective: a surveyComputer Physics Communications, 1996
- Comparison of simple potential functions for simulating liquid waterThe Journal of Chemical Physics, 1983